Brian Goff M.B.A. — Executive VP & Chief Commercial Officer at Alexion Pharmaceuticals

Mr. Brian Goff, M.B.A. has been Chief Commercial Officer and Executive Vice President at Alexion Pharmaceuticals, Inc. since June 01, 2017. Mr. Goff is a proven global biopharmaceutical executive with a 25-year track record of consistently delivering sustainable growth through multiple business cycles. He served as the Chief Operating Officer at Neurovance, Inc. from December 14, 2016 to March 2017. Mr. Goff served as an Executive Vice President and President of Hematology at Baxalta Incorporated since 2015 until mid-2016. Mr. Goff served as an Executive Officer of Primary Care Business Unit at Novartis AG. He served as Vice President and Head of Primary Care Marketing at Novartis AG. From June 2012 to December 2014, he served with Baxter Healthcare Corporation as Global Hemophilia Franchise Head. Prior to joining Baxter in 2012, Mr. Goff served as Vice President and Head of Novartis Pharmaceuticals' multi-billion-dollar Primary Care business. Previously at Novartis' Swiss headquarters, he led the global marketing of their flagship cardiovascular brand and he spent 14 years in a variety of commercial leadership positions at Johnson & Johnson ' including 10 years in CNS disorders. He held several positions at NPC from 2007 to April 2010, served as Vice President and Head of Primary Care Marketing and Customer Innovation Strategy. Prior to joining NPC, he served as Global Director for two of Novartis', key products. He joined Novartis in March 2005 following a 14-year career in sales and marketing at the pharmaceutical division of Johnson & Johnson. He served as a Director at Neurovance, Inc. from December 14, 2016 to March 2017. He served as a Director of Idenix Pharmaceuticals Inc., from March 2012 to May 15, 2012. He is a Member of the General Medicines Executive Committee at NPC. Mr. Goff holds a B.A. from Skidmore College and an M.B.A. from the Wharton School of the University of Pennsylvania.